Coherus and Junshi Biosciences Announce FDA Approval of
– LOQTORZI is the first and only FDA-approved treatment for NPC – – Indicated in combination with chemotherapy for 1st line treatment and as monotherapy...
Stay updated with breaking news from For Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– LOQTORZI is the first and only FDA-approved treatment for NPC – – Indicated in combination with chemotherapy for 1st line treatment and as monotherapy...
SHANGHAI, China, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leadi...
2024 KTM Duke 390 has been unveiled with a bigger engine, advanced features, and bold design, setting new standards in motorcycling excellence.
SHANGHAI, China, May 07, 2023 -- Shanghai Junshi Biosciences Co., Ltd announced a collaboration with Dr. Reddy’s Laboratories Limited to develop and commercialize toripalimab, the anti-PD-1... | May 7, 2023
Shanghai Junshi Biosciences and Dr. Reddy’s Laboratories have partnered for the development and commercialisation of toripalimab.